1. Home
  2. MYSZ vs CNSP Comparison

MYSZ vs CNSP Comparison

Compare MYSZ & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.64

Market Cap

2.2M

Sector

Technology

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$2.21

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
CNSP
Founded
1999
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.1M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
MYSZ
CNSP
Price
$0.64
$2.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
50.8K
23.1K
Earning Date
04-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
57.40
8.03
EPS
N/A
N/A
Revenue
$142,000.00
N/A
Revenue This Year
$41.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
N/A
52 Week Low
$0.50
$0.73
52 Week High
$1.65
$10.59

Technical Indicators

Market Signals
Indicator
MYSZ
CNSP
Relative Strength Index (RSI) 49.65 38.71
Support Level $0.52 $2.01
Resistance Level $0.68 $2.95
Average True Range (ATR) 0.04 0.27
MACD -0.00 0.01
Stochastic Oscillator 30.11 31.31

Price Performance

Historical Comparison
MYSZ
CNSP

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: